November 9, 2026
IQVIA Laboratories’ Laval, Quebec, Facility Earns Prestigious Containment Level 3 (CL3) Certification from the Public Health Agency of Canada and the Canadian Food Inspection Agency
This designation expands IQVIA Laboratories’ ability to support vaccine and ...
August 11, 2025
Luc Gagnon, IQVIA Laboratories’ global head of vaccine sciences, appointed to CEPI’s Global Central Laboratory Network Advisory Council
.
August 11, 2025
IQVIA Laboratories wins Vaccine Industry Excellence Award for Best Central/Specialty Laboratory for second consecutive year
.
March 4, 2025
IQVIA Laboratories Launches Site Lab Navigator with Breakthrough e-Requisition Innovation to Transform Clinical Trials
IQVIA Laboratories launches Site Lab Navigator, an advanced e-Requisition ...
October 9, 2024
IQVIA Laboratories Opens New State-of-the-Art Facility in Valencia, CA
IQVIA Laboratories announces the expansion and relocation of its Central ...
April 19, 2023
Q² Solutions strengthens scalable, next generation sequencing approaches with Illumina’s NovaSeq™ X Plus platform solution, enhancing data quality and analysis capabilities with sustainable operations
Expanding on deep expertise with industry-leading solutions to meet the unique ...
April 3, 2023
Q² Solutions Scotland-based Central Laboratory Achieves My Green Lab Program Certification
Showcasing commitment to sustainable laboratory practices, Q² Solutions is ...
March 31, 2023
Specifica Announces Antibody Discovery Platform Transfer Agreement with Servier and its Subsidiary Symphogen
Specifica is a rapidly growing antibody engineering company specializing in the ...
January 24, 2023
Q² Solutions Presents Benefits of Innovative Tech-Enabled End-to-End Sample and Consent Management at 14th Annual SCOPE Summit
Vital for trial sponsors looking to enhance trial efficiencies with quality and ...
November 16, 2022
